title: Fatal stroke and use of oral contraceptives: findings from a case-control study.
abstract: A case-control study of women less than 40 years of age in England and Wales was performed to evaluate the risk of fatal stroke associated with the use of the newer, low-dose oral contraceptives. Included were 296 cases with subarachnoid hemorrhage, 105 cases with other hemorrhagic stroke, and 21 cases with occlusive stroke, all of which occurred during 1986-1988. Two living controls per case, matched for age and marital status, were chosen from the general practice lists. The power of the study was such that the minimum significant increased relative risk of subarachnoid hemorrhage associated with ever having used oral contraceptives that could have been detected with 90% certainty was 1.6; the equivalent value for occlusive stroke was 28.4. Relative risk was estimated by conditional logistic regression allowing for matching. The adjusted relative risk of subarachnoid hemorrhage associated with oral contraceptives was estimated to be 1.1 (95% confidence interval (CI) 0.6-1.9) for current use and 1.3 (95% CI 0.9-1.8) for ever use, while the equivalent relative risk of an occlusive stroke associated with ever use was 4.4 (95% CI 0.8-24.4). Oral contraceptive use may be associated with a small increase in the risk of subarachnoid hemorrhage. These data are consistent with a substantial increase in the risk of occlusive stroke associated with oral contraceptive use.
authors.affiliation: Department of Public Health and Primary Care, University of Oxford, Radcliffe Infirmary, England.
authors.forename: M
authors.initials: M
authors.lastname: Thorogood
authors.forename: J
authors.initials: J
authors.lastname: Mann
authors.forename: M
authors.initials: M
authors.lastname: Murphy
authors.forename: M
authors.initials: M
authors.lastname: Vessey
mesh_terms: D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002561:Cerebrovascular Disorders / Q000139:chemically induced / Q000145:classification / Q000401:mortality*; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D003644:Death Certificates; D004739:England / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D016015:Logistic Models; D016555:Matched-Pair Analysis; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D013345:Subarachnoid Hemorrhage / Q000139:chemically induced / Q000401:mortality*; D011795:Surveys and Questionnaires; D014852:Wales / Q000453:epidemiology
chemical_list: D003276:Contraceptives, Oral